14. Characterizing response to checkpoint blockade treatment in mouse urothelial carcinoma model with scRNA

Freshour, Sharon; Fisk, Bryan; Mosior, Matthew; Bolzenius, Jennifer K.; Griffith, Obi L.; Arora, Vivek; Griffith, Malachi

doi:10.1016/j.cancergen.2020.04.018

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While one cluster with favorable prognosis was related to significantly increased CD4 + T cells and NK-cell infiltration, in the poor prognosis cluster, B cells, endothelial cells, and macrophages were enriched. In a mouse model of invasive BC, PD-1/CTLA-4 co-treatment induced IFN-γ response genes in multiple cell types, including endothelial cells [31]. Notably, antitumor effects of PD-1/CTLA-4 co-treatment were abrogated in an endothelial-specific IFNγR1-deficient bladder cancer mouse model, demonstrating that IFN-γ response of endothelial cells was essential for ICI treatment.…”

Section: Single-cell and Spatial Omics To Study Tumor Heterogeneity C...mentioning

confidence: 96%

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer

Grausenburger,

Herek,

Shariat

et al. 2024

Current Opinion in Urology

View full text Add to dashboard Cite

Purpose of review Current risk stratification and treatment decision-making for bladder cancer informed by histopathology as well as molecular diagnostics face limitations. This review summarizes recent advancements in single-cell and spatial omics methodologies for understanding bladder cancer biology and their potential impact on development of novel therapeutic strategies. Recent findings Single-cell RNA sequencing and spatial omics techniques offer unprecedented insights into various aspects of tumor microenvironment (TME), bladder cancer heterogeneity, cancer stemness, and cellular plasticity. Studies have identified multiple malignant cell subpopulations within tumors, revealing diverse transcriptional states and clonal evolution. Additionally, intratumor heterogeneity has been linked to tumor progression and therapeutic response. Immune cell composition analysis has revealed immunosuppressive features in the TME, impacting treatment response. Furthermore, studies have elucidated the role of cancer-associated fibroblasts and endothelial cells in shaping the tumor immune landscape and response to therapy. Summary Single-cell and spatial omics technologies have revolutionized our understanding of bladder cancer biology, uncovering previously unseen complexities. These methodologies provide valuable insights into tumor heterogeneity and microenvironmental interactions, with implications for therapeutic development. However, challenges remain in translating research findings into clinical practice and implementing personalized treatment strategies. Continued interdisciplinary collaboration and innovation are essential for overcoming these challenges and leveraging the full potential of single-cell and spatial omics in improving bladder cancer diagnosis and treatment.

show abstract

Section: Single-cell and Spatial Omics To Study Tumor Heterogeneity C...mentioning

confidence: 96%

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer

Grausenburger,

Herek,

Shariat

et al. 2024

Current Opinion in Urology

View full text Add to dashboard Cite

show abstract

14. Characterizing response to checkpoint blockade treatment in mouse urothelial carcinoma model with scRNA

Cited by 1 publication

References 0 publications

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer

Contact Info

Product

Resources

About